SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about press release

21 Mar 2022 Evaluate

Strides Pharma Science has informed that it enclosed a press release today titled ‘Strides partners with Medicines Patent Pool (MPP) to commercialize the generic version of Pfizer’s COVID-19 Oral Treatment across 95 markets.’

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

996.10 27.05 (2.79%)
06-Aug-2026 14:47 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1950.20
Dr. Reddys Labs. 1171.15
Cipla 1474.40
Lupin 2397.20
Zydus Lifesciences 1105.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: